Publications
What Challenges Will FDA Face In A Post-Chevron World?
Quoted, American Conference Institute
Chad Landmon, Hatch-Waxman & Biologics Chair, discusses the potential challenges the FDA may face in the aftermath of the US Supreme Court’s decision to eliminate the Chevron Doctrine.
